Evidence map›Paper›PMID 40514334›Full record

ArticleActa biomaterialia2025

Clickable PEG-norbornene microgels support suspension bioprinting and microvascular assembly.

Irene W Zhang, Lucia S Choi, Nicole E Friend, Atticus J McCoy, Firaol S Midekssa, Michael M Hu, Eben Alsberg, Sasha Cai Lesher-Pérez, Jan P Stegemann, Brendon M Baker and 1 more

Abstract read
In one paragraph

Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Biofabrication and Characterization of Vascularizing PEG-Norbornene Microgels.Journal of biomedical materials research. Part A · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Irene W ZhangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Lucia S ChoiDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Nicole E FriendDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Atticus J McCoyDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Firaol S MidekssaDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Michael M HuDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Eben AlsbergRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, United States; Jesse Brown Veterans Affairs Medical Center (JBVAMC), Chicago, IL, United States.
Sasha Cai Lesher-PérezDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, United States.
Jan P StegemannDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Brendon M BakerDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
Andrew J PutnamDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States. Electronic address: putnam@umich.edu.

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Regulation and Enhancement of Angiogenesis in Dense Fibrin MatricesR01HL085339 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTNAM, ANDREW J · 2007 to 2024
$5.4M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Training Program in Translational Cardiovascular Research and EntrepreneurshipT32HL125242 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICHELE, DANIEL E · 2015 to 2024
$1.9M
Angiogenic hydrogel composites for microvascular integration of organoid graftsR01EB030474 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAKER, BRENDON M · 2021 to 2024
$1.4M
NHLBI NIH HHS R01 HL085339NHLBI NIH HHS T32 HL125242NIBIB NIH HHS R01 EB030474NIDCR NIH HHS T32 DE007057NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

The development of perfusable and multiscale vascular networks remains one of the largest challenges in tissue engineering. As such, there is a need for the creation of customizable and facile methods to produce robustly vascularized constructs. In this study, secondarily crosslinkable (clickable) poly(ethylene glycol)-norbornene (PEGNB) microbeads were produced and evaluated for their ability to sequentially support suspension bioprinting and microvascular self-assembly towards the aim of engineering hierarchical vasculature. The clickable PEGNB microbead slurry exhibited mechanical behavior suitable for suspension bioprinting of sacrificial bioinks, could be UV crosslinked into a granular construct post-print, and withstood evacuation of the bioink and subsequent perfusion of the patterned void space. Endothelial and stromal cells co-embedded within jammed RGD-modified PEGNB microbead slurries assembled into capillary-scale vasculature after secondary crosslinking of the beads into granular constructs, with endothelial tubules forming within the interstitial space between microbeads and supported by the perivascular association of the stromal cells. Microvascular self-assembly was not impacted by printing sacrificial bioinks into the cell-laden microbead support bath before UV crosslinking. Collectively, these results demonstrate that clickable PEGNB microbeads are a versatile substrate for both suspension printing and microvascular culture and may be the foundation for a promising methodology to engineer hierarchical vasculature. STATEMENT OF SIGNIFICANCE: In this study, we leveraged and combined advances in microgel biomaterials, granular hydrogels, suspension bioprinting, and vascular biology to create relatively large volume (>500 mm

Indexed as

BioprintingClick ChemistryMicrogelsMicrovesselsNorbornanesPolyethylene GlycolsAnimalsHumansHuman Umbilical Vein Endothelial CellsMicrospheresTissue Engineering2-norborneneMicrogelsNorbornanesPolyethylene GlycolsMAP gelsMicrogelsPoly(ethylene glycol)Suspension bioprintingVascularization

Identifiers

PMID40514334
PMCPMC12277018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.